In addition, SP1 promotes NCX1 overexpression and attenuates brain edema, and the development of drugs that modulate NCX1 by promoting its upregulation in stroke or through epigenetic changes may be a novel pharmacological pathway to improve neuronal injury during cerebral ischemia. This evidence concerns the gene SLC8A1 and Cerebral ischemia.